AMPLIA THERAPEUTICS LIMITED revenue breakdown overview

AMPLIA THERAPEUTICS LIMITED revenue for the last year amounted to 100.00 M AUD, the most of which — 12.00 k AUD — came from its highest performing source at the moment, Focal Adhesion Kinase, the year earlier bringing 15.00 k AUD. The greatest contribution to the revenue figure was made by Australia — last year it brought AMPLIA THERAPEUTICS LIMITED 12.00 k AUD, and the year before that — 15.00 k AUD.